Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling.
Abstract
Free fatty acids (FFAs) are proposed to play a pathogenic role in both peripheral and hepatic insulin resistance. We have examined the effect of saturated FFA on insulin signalling (100 nM) in two hepatocyte cell lines. Fao hepatoma cells were treated with physiological concentrations of sodium palmitate (0.25 mM) (16:0) for 0.25-48 h. Palmitate decreased insulin receptor (IR) protein and mRNA expression in a dose- and time-dependent manner (35% decrease at 12 h). Palmitate also reduced insulin-stimulated IR and IRS-2 tyrosine phosphorylation, IRS-2-associated PI 3-kinase activity, and phosphorylation of Akt, p70 S6 kinase, GSK-3 and FOXO1A. Palmitate also inhibited insulin action in hepatocytes derived from wild-type IR (+/+) mice, but was ineffective in IR-deficient (-/-) cells. The effects of palmitate were reversed by triacsin C, an inhibitor of fatty acyl CoA synthases, indicating that palmitoyl CoA ester formation is critical. Neither the non-metabolized bromopalmitate alone nor the medium chain fatty acid octanoate (8:0) produced similar effects. However, the CPT-1 inhibitor (+/-)-etomoxir and bromopalmitate (in molar excess) reversed the effects of palmitate. Thus, the inhibition of insulin signalling by palmitate in hepatoma cells is dependent upon oxidation of fatty acyl-CoA species and requires intact insulin receptor expression.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
These effects in the liver appear to be mediated via reduced expression of the insulin receptor.
“These effects in the liver appear to be mediated via reduced expression of the insulin receptor (221).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [221]
Incubation of hepatocytes with saturated long-chain fatty acids induces insulin resistance by reducing insulin-stimulated tyrosine phosphorylation of the insulin receptor and its downstream substrates.
“At a cellular level, incubation of hepatocytes with saturated long-chain fatty acids induces insulin resistance by reducing insulin-stimulated tyrosine phosphorylation of the insulin receptor and its downstream substrates (220, 221).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [221]
Cites
1 retracted
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Taniguchi, C. M., Ueki, K., & Kahn, C. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23187 · Cited by 272 · see citing works
RetractedInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · see citing works
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · see citing works
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,079 · see citing works
International Journal of Obesity
(2019) · International Journal of Obesity · doi:10.1038/41366.1476-5497 · Cited by 2,092 · see citing works
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990 · see citing works
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D., Gutiérrez, J., Towery, H., Burks, D., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,850 · see citing works
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,837 · see citing works
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · see citing works
Itani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390 · see citing works
Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · see citing works
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · see citing works
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267 · see citing works
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism
Desvergne, B. (1999) · Endocrine Reviews · doi:10.1210/er.20.5.649 · Cited by 1,251 · see citing works
Holland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232 · see citing works
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80467-0 · Cited by 1,169 · see citing works
Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139 · see citing works
Self-citationCheatham, B., Vlahos, C. J., Cheatham, L. A., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902-4911.1994 · Cited by 1,067 · see citing works
Prevention of fat-induced insulin resistance by salicylate
Kim, J. K., Kim, Y.-J., Fillmore, J. J., Chen, Y., Moore, I., Lee, J., Yuan, M., Li, Z. W., Karin, M., Perret, P., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11559 · Cited by 737 · see citing works
Jiang, Z. Y., Lin, Y.-W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5971 · Cited by 604 · see citing works
Schmitz-Peiffer, C., Craig, D. L., & Biden, T. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24202 · Cited by 592 · see citing works
Boden, G., She, P., Mozzoli, M., Cheung, P., Gumireddy, K., Reddy, P., Xiang, X., Luo, Z., & Ruderman, N. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3458 · Cited by 528 · see citing works
Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α
Hertz, R., Magenheim, J., Berman, I., & Bar‐Tana, J. (1998) · Nature · doi:10.1038/33185 · Cited by 509 · see citing works
Samuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497 · see citing works
Webb, Y., Hermida-Matsumoto, L., & Resh, M. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.261 · Cited by 475 · see citing works
Koves, T. R., Li, P., An, J., Akimoto, T., Slentz, D., Ilkayeva, O., Dohm, G. L., Yan, Z., Newgard, C. B., & Muoio, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507621200 · Cited by 464 · see citing works
Fatty Acid Regulation of Gene Transcription
Duplus, E., Glorian, M., & Forest, C. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000015200 · Cited by 395 · see citing works
Paumen, M. B., Ishida, Y., Muramatsu, M., Yamamoto, M., & Honjo, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3324 · Cited by 349 · see citing works
Obesity-related derangements in metabolic regulation
Muoio, D. M., & Newgard, C. B. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142512 · Cited by 345 · see citing works
Hebert, L. F., Daniels, M. C., Zhou, J., Crook, E. D., Turner, R. L., Simmons, S. T., Neidigh, J. L., Zhu, J. S., Baron, A., & McClain, D. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118876 · Cited by 334 · see citing works
Self-citationRole of the glucosamine pathway in fat-induced insulin resistance.
Hawkins, M. A., Barzilai, N., Liu, R., Hu, M., Chen, W., & Rossetti, L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119390 · Cited by 324 · see citing works
Schmitz-Peiffer, C., Browne, C. L., Oakes, N. D., Watkinson, A., Chisholm, D. J., Kraegen, E. W., & Biden, T. J. (1997) · Diabetes · doi:10.2337/diab.46.2.169 · Cited by 314 · see citing works
Nakae, J., Barr, V. A., & Accili, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.989 · Cited by 270 · see citing works
Free Fatty Acid as a Link in the Regulation of Hepatic Glucose Output by Peripheral Insulin
Rebrin, K., Steil, G. M., Getty‐Kaushik, L., & Bergman, R. N. (1995) · Diabetes · doi:10.2337/diab.44.9.1038 · Cited by 270 · see citing works
Richardson, D. K., Kashyap, S., Bajaj, M., Cusi, K., Mandarino, S. J., Finlayson, J., DeFronzo, R. A., Jenkinson, C. P., & Mandarino, L. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408985200 · Cited by 259 · see citing works
Peroxisome Proliferator Activator Receptor γ Coactivator-1 Expression Is Reduced in Obesity
Crunkhorn, S., Dearie, F., Mantzoros, C., Gami, H., da Silva, W. S., Espinoza, D., Faucette, R., Barry, K., Bianco, A. C., & Patti, M. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611214200 · Cited by 236 · see citing works
Self-citationRapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans.
Roden, M., Krššák, M., Stingl, H., Gruber, S., Hofer, A., Fürnsinn, C., Moser, E., & Waldhäusl, W. K. (1999) · Diabetes · doi:10.2337/diabetes.48.2.358 · Cited by 189 · see citing works
Sindelar, D., Chu, C. A., Rohlie, M., Neal, D., Swift, L., & Cherrington, A. (1997) · Diabetes · doi:10.2337/diab.46.2.187 · Cited by 179 · see citing works
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168 · see citing works
Evidence That IRS-2 Phosphorylation Is Required for Insulin Action in Hepatocytes
Rother, K. I., Imai, Y., Caruso, M., Bèguinot, F., Formisano, P., & Accili, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17491 · Cited by 167 · see citing works
Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics.
Hennes, M. M. I., Shrago, E., & Kissebah, A. H. (1990) · PubMed · Cited by 90 · see citing works
Wolfrum, C., Börchers, T., Sacchettini, J. C., & Spener, F. (2000) · Biochemistry · doi:10.1021/bi991638u · Cited by 84 · see citing works
Prevention of fat-induced insulin resistance by salicylate
Kim, J. K., Kim, Y. J., Fillmore, J. J., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111559 · Cited by 80 · see citing works
Identification of a biochemical link between energy intake and energy expenditure
Obici, S., Wang, J., Chowdury, R., Feng, Z., Siddhanta, U., Morgan, K., & Rossetti, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15258 · Cited by 76 · see citing works
Bell-Anderson, K. S., Schmitz‐Peiffer, C., Lim-Fraser, M., Biden, T. J., Cooney, G. J., & Kraegen, E. W. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1196 · Cited by 53 · see citing works
Differential Signaling of Insulin and IGF-1 Receptors to Glycogen Synthesis in Murine Hepatocytes
Park, B., Kido, Y., & Accili, D. (1999) · Biochemistry · doi:10.1021/bi9830718 · Cited by 45 · see citing works
Nuclear Forkhead Box O1 Controls and Integrates Key Signaling Pathways in Hepatocytes
Naïmi, M., Gautier, N., Chaussade, C., Valverde, Á. M., Accili, D., & OBBERGHEN, E. V. (2007) · Endocrinology · doi:10.1210/en.2006-1411 · Cited by 41 · see citing works
Hypoglycemic effects of a novel fatty acid oxidation inhibitor in rats and monkeys
Deems, R. O., Anderson, R. C., & Foley, J. E. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.2.r524 · Cited by 35 · see citing works
Fatty acid represses insulin receptor gene expression by impairing HMGA1 through protein kinase Cε
Dey, D., Bhattacharya, A., Roy, S., & Bhattacharya, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.183 · Cited by 32 · see citing works
Usui, I., Takata, Y., Imamura, T., Morioka, H., Sasaoka, T., Sawa, T., Ishihara, H., Ishiki, M., & Kobayashi, M. (1997) · Diabetologia · doi:10.1007/s001250050765 · Cited by 30 · see citing works
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Taniguchi, C. M., Ueki, K., & Kahn, C. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523187 · Cited by 23 · see citing works
Spurway, T. D., Pogson, C. I., Sherratt, H. S. A., et al. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00103-8 · Cited by 22 · see citing works
Kriauciunas, K. M., Goldstein, B. J., Lipes, M. A., et al. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041540306 · Cited by 15 · see citing works
Identification of a biochemical link between energy intake and energy expenditure
Obici, S., Wang, J., Chowdury, R., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215258 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The role of mitochondria in the pathogenesis of type 2 diabetes
Patti, M.-E., & Corvera, S. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0027 · Cited by 551 · see citing works
Self-citationImpact of nutrients on circadian rhythmicity
Oosterman, J. E., Kalsbeek, A., la Fleur, S. E., & Belsham, D. D. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00322.2014 · Cited by 221 · see citing works
Lipina, C., Macrae, K., Suhm, T., Weigert, C., Blachnio-Zabielska, A., Baranowski, M., Gorski, J., Burgess, K., & Hundal, H. S. (2013) · Diabetes · doi:10.2337/db13-0264 · Cited by 26 · see citing works
Retracted
- Authors
- Ruddock, M. W., Stein, A., Landaker, E., Park, J., Cooksey, R. C., McClain, D., & Patti, M.-E.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- Ruddock, M. W.
- Venue
- Journal of Biochemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-08-11
- Volume
- 144
- Issue
- 5
- Pages
- 599-607
- ISSN
- 0021-924X (ISSN-L)
- OpenAlex
- W2046497969
- Cited by
- 75
- References
- 54
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 2 · 2019: 2 · 2017: 2 · 2016: 1 · 2015: 9 · 2014: 11 · 2013: 7 · 2012: 5
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institutes of Health (5k08dk002526-03)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK02526, DK-62948, R01DK062948)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- saturated fatty acids, palmitate, hepatic insulin resistance, insulin receptor expression, insulin receptor tyrosine phosphorylation, insulin receptor substrate 2, Akt phosphorylation, glycogen synthase kinase-3, FOXO1, p70 S6 kinase, fatty acid oxidation, hepatocytes, insulin signaling
- MeSH terms
- Aminoimidazole Carboxamide, Animals, Enzyme Activation, Enzyme Inhibitors, Epoxy Compounds, Fatty Acids, Fatty Acids, Nonesterified, Carcinoma, Hepatocellular, Hypoglycemic Agents, Insulin, Liver, Liver Neoplasms, Oxidation-Reduction, Phosphorylation, Receptor, Insulin, Ribonucleotides, Triazenes, Signal Transduction, Mice, Knockout, Palmitic Acid, Phosphatidylinositol 3-Kinases, Glycogen Synthase Kinase 3, Cell Line, Tumor, Extracellular Signal-Regulated MAP Kinases, p38 Mitogen-Activated Protein Kinases, Proto-Oncogene Proteins c-akt, Mice, Rats, Forkhead Transcription Factors, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review